ENTRY       K06643                      KO
NAME        MDM2
DEFINITION  E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]
PATHWAY     ko04068  FoxO signaling pathway
            ko04110  Cell cycle
            ko04115  p53 signaling pathway
            ko04120  Ubiquitin mediated proteolysis
            ko04144  Endocytosis
            ko04151  PI3K-Akt signaling pathway
            ko04919  Thyroid hormone signaling pathway
            ko05169  Epstein-Barr virus infection
            ko05200  Pathways in cancer
            ko05202  Transcriptional misregulation in cancer
            ko05203  Viral carcinogenesis
            ko05205  Proteoglycans in cancer
            ko05206  MicroRNAs in cancer
            ko05214  Glioma
            ko05215  Prostate cancer
            ko05218  Melanoma
            ko05219  Bladder cancer
            ko05220  Chronic myeloid leukemia
DISEASE     H00025  Penile cancer
            H00028  Choriocarcinoma
            H00036  Osteosarcoma
            H00037  Alveolar rhabdomyosarcoma
            H00042  Glioma
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Genetic Information Processing
              Folding, sorting and degradation
               04120 Ubiquitin mediated proteolysis
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
             Environmental Information Processing
              Signal transduction
               04068 FoxO signaling pathway
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               04151 PI3K-Akt signaling pathway
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
             Cellular Processes
              Transport and catabolism
               04144 Endocytosis
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
              Cell growth and death
               04110 Cell cycle
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               04115 p53 signaling pathway
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
             Organismal Systems
              Endocrine system
               04919 Thyroid hormone signaling pathway
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05202 Transcriptional misregulation in cancers
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05206 MicroRNAs in cancer
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05205 Proteoglycans in cancer
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05203 Viral carcinogenesis
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05214 Glioma
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05220 Chronic myeloid leukemia
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05218 Melanoma
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05219 Bladder cancer
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
               05215 Prostate cancer
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
              Infectious diseases
               05169 Epstein-Barr virus infection
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
            Enzymes [BR:ko01000]
             6. Ligases
              6.3  Forming carbon-nitrogen bonds
               6.3.2  Acid-D-amino-acid ligases (peptide synthases)
                6.3.2.19  ubiquitin---protein ligase
                 K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
            Ubiquitin system [BR:ko04121]
             Ubiquitin ligases (E3)
              single Ring-finger type E3
               MDM2/MDM4 proteins
                K06643  MDM2; E3 ubiquitin-protein ligase Mdm2
DBLINKS     GO: 0017163
GENES       HSA: 4193(MDM2)
            PTR: 742141(MDM2)
            PPS: 100968756(MDM2)
            GGO: 101129964(MDM2)
            PON: 100171532(MDM2)
            MCC: 718284(MDM2)
            MCF: 102136323(MDM2)
            MMU: 17246(Mdm2)
            RNO: 314856(Mdm2)
            CGE: 100770120(Mdm2)
            HGL: 101724821(Mdm2)
            TUP: 102473924(MDM2)
            CFA: 403693(MDM2)
            AML: 100479481
            FCA: 493939(MDM2)
            PTG: 102965880(MDM2)
            BTA: 540378(MDM2)
            BOM: 102287490(MDM2)
            PHD: 102322496 102339259(MDM2)
            CHX: 102173163(MDM2)
            SSC: 100125959(MDM2)
            CFR: 102522420(MDM2)
            BACU: 103017808(MDM2)
            LVE: 103081431(MDM2)
            ECB: 100052084(MDM2)
            MYB: 102256024(MDM2)
            MYD: 102751322 102759555 102771162(MDM2)
            PALE: 102884281(MDM2)
            MDO: 100021398(MDM2)
            SHR: 100919874(MDM2) 100920321
            OAA: 100080712(MDM2)
            GGA: 395609(MDM2)
            MGP: 100546889
            TGU: 100228592(MDM2)
            FAB: 101813089(MDM2)
            PHI: 102099986(MDM2)
            APLA: 101805150(MDM2)
            FPG: 101924125(MDM2)
            FCH: 102048171(MDM2)
            CLV: 102085264(MDM2)
            ASN: 102385768(MDM2)
            AMJ: 102561091(MDM2)
            PSS: 102447336(MDM2)
            CMY: 102948375(MDM2)
            ACS: 100556723
            PBI: 103063483(MDM2)
            XLA: 444499(mdm2)
            XTR: 394853(mdm2)
            DRE: 30637(mdm2)
            TRU: 101068181
            MZE: 101466094
            OLA: 101174634
            XMA: 102234130
            LCM: 102353921(MDM2)
            CMK: 103185308(mdm2)
            BFO: BRAFLDRAFT_117290
            SPU: 100893740
            TCA: 664204
            BMOR: 101745393
            PHU: Phum_PHUM209440
            ISC: IscW_ISCW023507
            HMG: 100205294
            TAD: TRIADDRAFT_54791
REFERENCE   PMID:19498444
  AUTHORS   Marine JC, Lozano G
  TITLE     Mdm2-mediated ubiquitylation: p53 and beyond.
  JOURNAL   Cell Death Differ 17:93-102 (2010)
REFERENCE   PMID:19965871
  AUTHORS   Taira N, Yamamoto H, Yamaguchi T, Miki Y, Yoshida K
  TITLE     ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.
  JOURNAL   J Biol Chem 285:4909-19 (2010)
///
